The Hill reports:
The former drug company executive leading the Trump administration’s coronavirus vaccine initiative said he will divest all his shares in Moderna, one of the initiative’s leading candidates.
At the time of his appointment to lead “Operation Warp Speed,” the shares were worth about $10 million. The announcement comes as Moderna’s stock soared almost 20 percent on Monday, following promising early results from its phase one vaccine trial.
Watchdog organizations and some congressional Democrats have called for Slaoui to divest his holdings, calling them a major conflict of interest.